NMR and 13 C NMR spectra. 1 Synthesis of Compound 1: 4-Cyanophenylboronic acid (1.11 g, 7.50 mmol), 2,5-dibromofuran (847 mg, 3.75 mmol) and tetrakis(triphenylphosphine)palladium(0) (300 mg, 0.26 mmol) were S-3 added to a round bottom flask. The flask was then flushed with argon for 3 minutes before adding 15 mL toluene, 7.5 mL isopropanol and 7.5 mL of an aqueous 2 M sodium carbonate solution. The reaction mixture was then heated to 80 °C and allowed to stir for 20 hours to allow the reaction to occur. Upon completion, the reaction mixture was allowed to cool to room temperature resulting in a precipitate that was filtered to give 1 as yellow green solid (758 mg, 75% yield). Note: Compound 1 is a known compound (CAS No.: 55368-37-1) and was synthesized according to a modified literature procedure (63) . The 1 H NMR tabulation data and melting point (>250 °C) that we obtained for 1 matched those previously reported (64).
Synthesis of Compound 2:
Hydroxylamine hydrochloride (2.57 g, 37 mmol) was dissolved in anhydrous dimethyl sulfoxide under an argon atmosphere. Then potassium tert-butoxide (3.56 g, 37mmol) was added slowly to this mixture at 0 °C, which was partially frozen. The resulting mixture was allowed to stir at 0 °C for 20 minutes before the addition of compound 1. The reaction was then stirred at room temperature for 21.5 hours. Upon completion, the reaction mixture was slowly poured into a beaker containing ice water forming a white precipitate. This mixture was allowed to stir for 15 minutes, then the white precipitate was filtered and washed with water to afford compound 2 as a free base. Finally, the free base of 2 was added to a solution of 5 M hydrochloric acid in isopropanol (20 mL) and allowed to stir. After a few minutes, this solution was then diluted with ether and the precipitate that formed was collected by filtration to give bis-hydrochloride salt of 2 (671 mg, 87% yield). Note: Compound 2 is a known compound (CAS No.: 186953-55-9) and was synthesized according to a modified procedure (65). No spectra for 2 were found for comparison in our search, so we have provided our data in this report. MP: > 250 °C, lit. > 350 °C (66). 152.4, 133.8, 128.7, 124.2, 123.9, 111 .4.
S-4

S-5
Synthesis of Pafuramidine: Compound 2 (233 mg, 0.57 mmol) was dissolved in dimethylformamide (14 mL). Then, a solution of lithium hydroxide (144 mg, 3.42 mmol) in water (2.1 mL) was added to the stirring solution of 2 in dimethylformamide and allowed to stir for 30 minutes before dimethylsulfate (135 µL, 1.43 mmol) was added dropwise at room temperature. The reaction was then heated to 40 °C and stirred for 20 hours. Upon completion of this reaction, the mixture was allowed to cool to room temperature. The reaction mixture was then poured slowly into a beaker containing ice water resulting in the formation of a precipitate.
The resulting mixture was allowed to stir for 15 minutes, afterwards the white precipitate was collected by filtration and purified using flash column chromatography using 99.5:0.5 dichloromethane:methanol as the eluent to afford Pafuramidine as a white solid (102 mg, 49% yield). Note: Pafuramidine is a known compound (CAS No.: 186953-56-0) and was synthesized according to a modified literature procedure (65) . No spectra of pafuramidine were found for comparison in our search, so we have provided our data in this report. HRMS (ESI): calc. for C20H21N4O3 [M+H] + : 365.1608, found: 365.1621. MP: 188 -190 °C, lit. 192.5 -193 °C (66) . protein levels at 0.25, 0.5, and 0.75 µM furamidine. Erythromycin treatment alone did not affect MBNL1 protein levels, but it did decrease MBNL2 protein levels at 50 µM. All combination treatments showed the same trends in MBNL1 and 2 protein levels as the corresponding furamidine treatment (* = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001). 
